However, this immuno-modulating effect to which Dr. Rudd refers is centered on enhanced CD8+ T lymphocyte (CTL) and NK cell effector functions, two factors implicated in muscle tissue destruction in IBM, and not on the pro-inflammatory cytokine storm. This evidence concerns the gene CD8A and inclusion body myositis.